Management of Chemotherapy-Induced Thrombocytopenia in Children
Immediate Assessment and Management
- Thrombocytopenia is the most likely cause of bruising in children receiving chemotherapy and requires immediate laboratory confirmation to guide management decisions, according to the American Society of Hematology 1
- Hold all anticoagulation including prophylactic low-molecular-weight heparin (LMWH) if the child is receiving thromboprophylaxis, as recommended by the American College of Clinical Pharmacy 1
- Administer platelet transfusions to maintain counts >20 × 10⁹/L for prophylaxis or >50 × 10⁹/L if active bleeding is present, as suggested by the American Society of Hematology 1
- Avoid intramuscular injections and invasive procedures, as advised by the American Academy of Pediatrics 1
Chemotherapy-Specific Considerations
- Asparaginase causes complex hemostatic changes including both bleeding and thrombotic complications, and consider higher prophylactic LMWH dosing or anti-Xa monitoring in patients receiving asparaginase, according to the American Society of Clinical Oncology 1
- Monitor fibrinogen levels, as asparaginase commonly causes hypofibrinogenemia, as recommended by the American Society of Hematology 1
- Ifosfamide can cause additional complications including renal dysfunction and Fanconi syndrome, which may contribute to bleeding risk through multiple mechanisms, as reported by the National Institute of Health 3
Critical Pitfalls to Avoid
- Failure to recognize severe thrombocytopenia can lead to life-threatening hemorrhage including intracranial bleeding, as warned by the American Society of Hematology 1
- Complete hematologic evaluation must precede any consideration of alternative diagnoses, as emphasized by the American Academy of Pediatrics 2
- Waiting for "more serious" bleeding before transfusing increases morbidity and mortality risk, as cautioned by the American Society of Hematology 1
Patient and Family Education
- Educate families that unusual bleeding or bruising requires immediate medical attention, as many patients underestimate the urgency of this symptom, according to the American Cancer Society 2